Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients

Journal of Hepatology

Volumn 27, Issue 1, 1997, Pages 72-77

  Khorsi, Hafida ^b   Castelain, Sandrine ^b   Wyseur, Ann ^a   Izopet, Jacques ^b   Canva, Valérie ^b   Rombout, Annelies ^a   Capron, Dominique ^b   Capron, Jean Pierre ^b   Lunel, Françoise ^b   Stuyver, Lieven ^a   Duverlie, Gilles ^b  

^a INNOGENETICS   (Belgium)

^b NONE

Author keywords

Genotypes; Hepatitis C virus; Interferon; Interferon sensitivity determining region; Viral load

Indexed keywords

ALPHA2A INTERFERON; ALPHA2B INTERFERON; AMINO ACID; HEPATITIS C ANTIBODY; RECOMBINANT ALPHA INTERFERON; VIRUS RNA;

AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; DRUG RESISTANCE; DRUG SENSITIVITY; ENZYME IMMUNOASSAY; FEMALE; FRANCE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; INTRAMUSCULAR DRUG ADMINISTRATION; JAPAN; LIVER BIOPSY; MALE; MUTANT; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 18344402297     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80282-6     Document Type: Article

References (14)

1. Laurent-Puig P, Dussaix E, Altman C. Host and viral characteristics affecting the response to interferon therapy in chronic hepatitis C. Eur J Gastroenterol Hepatol. 7:1995;335-340.
2. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, et al. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology. 22:1995;1050-1056.
3. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b: sensitivity to interferon is conferred by amino-acid substitutions in the NS5A region. J Clin Invest. 96:1995;224-230.
4. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med. 334:1996;77-81.
5. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Vanheuverswyn H, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol. 74:1993;1093-1102.
6. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal Biochem. 162:1987;156-159.
7. Richterich P, Church GM. DNA sequencing with direct transfer electrophoresis and non-radioactive detection. Methods Enzymol. 218:1993;187-222.
8. Miskovsky E, Carrella A, Gutekunst K, Sun C-A, Quinn T, Thomas D. Clinical characterization of a competitive PCR assay for quantitative testing of hepatitis C virus. J Clin Microbiol. 34:1996;1975-1979.
9. Nousbaum J-B, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C, et al. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med. 122:1995;161-168.
10. Pawlotsky J-M, Tsakiris L, Roudotthoraval F, Pellet C, Stuyver L, Duval J, et al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis. 171:1995;1607-1610.
11. Hino K, Sainokami S, Shimoda K, Iino S, Wang Y, Okamoto H, et al. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol. 42:1994;299-305.
12. Enomoto N, Sato C. Clinical relevance of hepatitis C virus quasispecies. J Viral Hepatitis. 2:1995;267-272.
13. Shimotohno K, Tanji Y, Hirowatari Y, Komoda Y, Kato N, Hijikata M. Processing of the hepatitis C virus precursor protein. J Hepatol. 22:1995;S87-S92. (Suppl 1).
14. Tanji Y, Kaneko T, Satoh S, Shimotohno K. Phosphorylation of hepatitis C virus encoded non-structural protein NS5A. J Virol. 69:1995;3980-3986.